Skip to main content
. 2022 Sep 16;14(18):4503. doi: 10.3390/cancers14184503

Figure 9.

Figure 9

Prediction of the response to common chemotherapy drugs between the low-risk and high-risk groups. (A) Estimation of IC50 value for Gemcitabine, Gefitinib, Cisplatin, Bleomycin, AKT. inhibitor. VIII, Imatinib. (B) Scatter plot of the association between three ORGs expression and drug sensitivity.